OC/LEP (Oral Contraception, Low Dose Estrogen Progestin) Market Research 2024 Featuring Johnson & Johnson, Sanofi, Novartis, Pfizer, Bayer, Merck, Teva, Abbvie, Viatris, and Cipla
September 12, 2024 09:55 ET
|
Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Global OC/LEP Market (2024 Edition): Analysis by Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel, By Region, By...
Recent Lancet Study Highlights Potential for Increased Emergency Contraception Efficacy - A Glimpse into the Flourishing Global Contraceptive Market
October 04, 2023 12:18 ET
|
Research and Markets
Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- A groundbreaking discovery, as reported by the medical journal Lancet, has brought to light that combining a common arthritis drug with the morning-after...
Progestin Options Set to Dominate Contraceptive Pills Market: Insights from 2023 to 2030
September 25, 2023 07:28 ET
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Global Contraceptive Pills Market by Hormone Type (Combination Pills, Progestin Pills), Category (Branded, Generic) - Cumulative Impact of COVID-19,...
$31+ Billion Worldwide Contraceptives Industry to 2031 - Rising Frequency of STIs or Diseases is Driving Demand
January 25, 2023 09:23 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "Contraceptives Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers...